Policy
FDA’s landmark decision to phase out animal testing | A new era for drug discovery and human cell models
bit.bio's perspective on the FDA's groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods.
14.04.2025bit.bio's perspective on the FDA's groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods.
